• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Marcus Wilson Discusses How Comparative Effectiveness Research is Used in the Managed Care Setting

Article

Marcus D. Wilson, PharmD, President, HealthCore, states that there is variability within and between different organizations that utilize comparative effectiveness research.

Marcus D. Wilson, PharmD, President, HealthCore, states that there is variability within and between different organizations that utilize comparative effectiveness research.

Comparative effectiveness research is used to better understand populations impacted by decisions, and is used to customize policy for specific populations.

Related Videos
Nicoletta Colombo, MD, PhD
Khush Kharidia, MD
Jo Varshney, PhD, DVM, CEO and founder, VeriSIM Life
Kimberly Westrich, MA, chief strategy officer, National Pharmaceutical Council
Harry Travis, BS Pharm, MBA, president at The Travis Group, LLC
Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
Chelsea Renfro, PharmD, research and engagement pharmacist, Vanderbilt Specialty Pharmacy
Marc S. Raab, MD, PhD, University Hospital Heidelberg
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Screenshot of an interview with Kristina Crothers, MD
Related Content
The findings underscore the importance of comprehensive clinical decision-making, including analysis of clinical and radiological “red flags” for both MS and MOGAD. | Image credit: luchschenF - stock.adobe.com

MOG-IgG Rare in Asian Patients With Multiple Sclerosis

October 31st 2025
Article

The study underscores the importance of repeat testing in cases where myelin oligodendrocyte glycoprotein immunoglobulin G tests are borderline.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

October 30th 2025
Podcast

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

Chronic spontaneous urticaria was significantly associated with an increased risk of several predefined cardiovascular outcomes. | Image credit: inthasone - stock.adobe.com

Chronic Spontaneous Urticaria Linked to Increased Heart Disease Risk

October 30th 2025
Article

There is a significant link between chronic spontaneous urticaria and cardiovascular disease risk, highlighting the need for routine assessments.

Read More

Managed Care Cast Square thumbnail

Advocacy, Access, and Awareness: Addressing Barriers in Hearing Health

October 28th 2025
Podcast

Discover how the Hearing Loss Association of America advocates for hearing loss awareness and hearing health integration through a dialogue with Barbara Kelley, executive director.

Listen

Emma Guttman-Yassky, MD, PhD | Image Credit: © Icahn School of Medicine at Mount Sinai

Combination and Monotherapy Data Highlight Rocatinlimab’s Real-World Potential in AD: A Q&A With Emma Guttman-Yassky, MD, PhD

October 30th 2025
Article

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Read More

Patients with non-scarring alopecia were found to be more affected in their psychological well-being compared with those with scarring alopecia. | Image credit: KApeopleimages - stock.adobe.com

Psychological Burden of Alopecia Significantly Impacts Quality of Life

October 30th 2025
Article

Hair loss disorder can lead to a significant psychological and emotional burden that warrants more attention, new research suggests.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.